Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

February 1, 2023; Volume 64,Issue 2

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 8A;

Discussions with Leaders

  • You have access
    Advancing Clinical Trial Innovation in Pancreatic Cancer
    Diane M. Simeone, Ken Herrmann and Johannes Czernin
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 185-187; DOI: https://doi.org/10.2967/jnumed.123.265432

The State of the Art

  • Open Access
    Artificial Intelligence in Nuclear Medicine: Opportunities, Challenges, and Responsibilities Toward a Trustworthy Ecosystem
    Babak Saboury, Tyler Bradshaw, Ronald Boellaard, Irène Buvat, Joyita Dutta, Mathieu Hatt, Abhinav K. Jha, Quanzheng Li, Chi Liu, Helena McMeekin, Michael A. Morris, Peter J.H. Scott, Eliot Siegel, John J. Sunderland, Neeta Pandit-Taskar, Richard L. Wahl, Sven Zuehlsdorff and Arman Rahmim
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 188-196; DOI: https://doi.org/10.2967/jnumed.121.263703

Hot Topics

  • Whole-Body PET Imaging: A Catalyst for Whole-Person Research?
    You have access
    Whole-Body PET Imaging: A Catalyst for Whole-Person Research?
    Lalith Kumar Shiyam Sundar, Marcus Hacker and Thomas Beyer
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 197-199; DOI: https://doi.org/10.2967/jnumed.122.264555

Issues and Controversies

  • Scientific Fraud, Publication Bias, and Honorary Authorship in Nuclear Medicine
    You have access
    Scientific Fraud, Publication Bias, and Honorary Authorship in Nuclear Medicine
    Thomas C. Kwee, Maan T. Almaghrabi and Robert M. Kwee
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 200-203; DOI: https://doi.org/10.2967/jnumed.122.264679

Procedure Standard

  • You have access
    SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors
    Thomas A. Hope, Martin Allen-Auerbach, Lisa Bodei, Jeremie Calais, Magnus Dahlbom, Lisa K. Dunnwald, Michael M. Graham, Heather A. Jacene, Courtney Lawhn Heath, Erik S. Mittra, Chadwick L. Wright, Wolfgang P. Fendler, Ken Herrmann, David Taïeb and Andreas Kjaer
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 204-210; DOI: https://doi.org/10.2967/jnumed.122.264860

Theranostics

  • Clinical

    • FEATURED ARTICLE OF THE MONTH

      • Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant <sup>225</sup>Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study
        You have access
        Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant 225Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study
        Sanjana Ballal, Madhav P. Yadav, Madhavi Tripathi, Ranjit Kumar Sahoo and Chandrasekhar Bal
        Journal of Nuclear Medicine February 1, 2023, 64 (2) 211-218; DOI: https://doi.org/10.2967/jnumed.122.264043
    • INVITED PERSPECTIVE

      • You have access
        The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the Field
        Jonathan Strosberg, Ken Herrmann and Lisa Bodei
        Journal of Nuclear Medicine February 1, 2023, 64 (2) 219-220; DOI: https://doi.org/10.2967/jnumed.122.264805
    • Evaluation of <sup>177</sup>Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective <sup>177</sup>Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)
      You have access
      Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)
      Sarennya Pathmanandavel, Megan Crumbaker, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Adam Hickey, Peter Eu, Martin Stockler, Andrew J. Martin, Anthony M. Joshua, Andrew Nguyen and Louise Emmett
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 221-226; DOI: https://doi.org/10.2967/jnumed.122.264398
    • Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99m</sup>Tc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
      Open Access
      Eligibility for 177Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
      Gary J.R. Cook, Wai-Lup Wong, Bal Sanghera, Stephen Mangar, Amarnath Challapalli, Amit Bahl, Paul Bassett, Darren Leaning and Christian Schmidkonz
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 227-231; DOI: https://doi.org/10.2967/jnumed.122.264296
  • Translational

    • FEATURED TRANSLATIONAL SCIENCE ARTICLE

      • <sup>68</sup>Ga-DOTATATE Prepared from Cyclotron-Produced <sup>68</sup>Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients
        Open Access
        68Ga-DOTATATE Prepared from Cyclotron-Produced 68Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients
        Sébastien Tremblay, Jean-François Beaudoin, Ophélie Bélissant Benesty, Samia Ait-Mohand, Véronique Dumulon-Perreault, Étienne Rousseau, Éric E. Turcotte and Brigitte Guérin
        Journal of Nuclear Medicine February 1, 2023, 64 (2) 232-238; DOI: https://doi.org/10.2967/jnumed.121.263768

Oncology

  • Clinical

    • Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2—Technical)
      You have access
      Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2—Technical)
      Fabien Ricard, Sally Barrington, Ron Korn, Guenther Brueggenwerth, Judith Trotman, Bruce Cheson, Gilles Salles, Larry Schwartz, Greg Goldmacher, Rudresh Jarecha, Jayant Narang, Florence Broussais, Paul Galette, Min Liu, Surabhi Bajpai, Eric Perlman, Julie Gillis, Ira Smalberg, Pierre Terve, Gudrun Zahlmann and Annette Schmid
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 239-243; DOI: https://doi.org/10.2967/jnumed.122.264124
    • Static and Dynamic <sup>68</sup>Ga-FAPI PET/CT for the Detection of Malignant Transformation of Intraductal Papillary Mucinous Neoplasia of the Pancreas
      You have access
      Static and Dynamic 68Ga-FAPI PET/CT for the Detection of Malignant Transformation of Intraductal Papillary Mucinous Neoplasia of the Pancreas
      Matthias Lang, Anna-Maria Spektor, Thomas Hielscher, Jorge Hoppner, Frederik M. Glatting, Felix Bicu, Thilo Hackert, Ulrike Heger, Thomas Pausch, Ewgenija Gutjahr, Hendrik Rathke, Frederik L. Giesel, Clemens Kratochwil, Christine Tjaden, Uwe Haberkorn and Manuel Röhrich
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 244-251; DOI: https://doi.org/10.2967/jnumed.122.264361
    • Prospective Phase II Trial of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET/CT Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for Prognostication in Patients with Neuroendocrine Neoplasms
      You have access
      Prospective Phase II Trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT Imaging of Integrin αvβ3 for Prognostication in Patients with Neuroendocrine Neoplasms
      Esben Andreas Carlsen, Mathias Loft, Annika Loft, Dorota Czyzewska, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 252-259; DOI: https://doi.org/10.2967/jnumed.122.264383

Cardiology

  • Clinical

    • Precision of Myocardial Blood Flow and Flow Reserve Measurement During CZT SPECT Perfusion Imaging Processing: Intra- and Interobserver Variability
      Open Access
      Precision of Myocardial Blood Flow and Flow Reserve Measurement During CZT SPECT Perfusion Imaging Processing: Intra- and Interobserver Variability
      Matthieu Bailly, Frédérique Thibault, Gilles Metrard, Maxime Courtehoux, Denis Angoulvant and Maria Joao Ribeiro
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 260-265; DOI: https://doi.org/10.2967/jnumed.122.264454

Neurology

  • Clinical

    • Early-Phase <sup>18</sup>F-Florbetapir and <sup>18</sup>F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting
      You have access
      Early-Phase 18F-Florbetapir and 18F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting
      Cecilia Boccalini, Débora Elisa Peretti, Federica Ribaldi, Max Scheffler, Sara Stampacchia, Szymon Tomczyk, Cristelle Rodriguez, Marie-Louise Montandon, Sven Haller, Panteleimon Giannakopoulos, Giovanni B. Frisoni, Daniela Perani and Valentina Garibotto
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 266-273; DOI: https://doi.org/10.2967/jnumed.122.264256
    • You have access
      Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on 18F-FDG PET Patterns in Clinical Alzheimer Disease
      Jesús Silva-Rodríguez, Miguel A. Labrador-Espinosa, Alexis Moscoso, Michael Schöll, Pablo Mir, Michel J. Grothe and for the Alzheimer’s Disease Neuroimaging Initiative
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 274-280; DOI: https://doi.org/10.2967/jnumed.122.264213
    • Longitudinal Tau PET Using <sup>18</sup>F-Flortaucipir: The Effect of Relative Cerebral Blood Flow on Quantitative and Semiquantitative Parameters
      Open Access
      Longitudinal Tau PET Using 18F-Flortaucipir: The Effect of Relative Cerebral Blood Flow on Quantitative and Semiquantitative Parameters
      Denise Visser, Hayel Tuncel, Rik Ossenkoppele, Maqsood Yaqub, Emma E. Wolters, Tessa Timmers, Emma Weltings, Emma M. Coomans, Marijke E. den Hollander, Wiesje M. van der Flier, Bart N.M. van Berckel and Sandeep S.V. Golla
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 281-286; DOI: https://doi.org/10.2967/jnumed.122.263926
    • Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease
      You have access
      Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease
      Shaney Flores, Charles D. Chen, Yi Su, Aylin Dincer, Sarah J. Keefe, Nicole S. McKay, Angela M. Paulick, Gloria Guzman Perez-Carrillo, Liang Wang, Russ C. Hornbeck, Manu Goyal, Andrei Vlassenko, Sally Schwarz, Michael L. Nickels, Dean F. Wong, Zhude Tu, Jonathan E. McConathy, John C. Morris, Tammie L.S. Benzinger and Brian A. Gordon
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 287-293; DOI: https://doi.org/10.2967/jnumed.122.263948
    • SPECIAL CONTRIBUTION

      • You have access
        The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
        Anne M. Smith, Nancy A. Obuchowski, Norman L. Foster, Gregory Klein, P. David Mozley, Adriaan A. Lammertsma, Richard L. Wahl, John J. Sunderland, Jean-Luc Vanderheyden, Tammie L.S. Benzinger, Paul E. Kinahan, Dean F. Wong, Eric S. Perlman, Satoshi Minoshima and Dawn Matthews
        Journal of Nuclear Medicine February 1, 2023, 64 (2) 294-303; DOI: https://doi.org/10.2967/jnumed.122.264031

AI/Advanced Image Analysis

  • Clinical

    • Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on <sup>18</sup>F-FDG PET/MRI and Machine Learning
      You have access
      Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning
      Janna Morawitz, Benjamin Sigl, Christian Rubbert, Nils-Martin Bruckmann, Frederic Dietzel, Lena J. Häberle, Saskia Ting, Svjetlana Mohrmann, Eugen Ruckhäberle, Ann-Kathrin Bittner, Oliver Hoffmann, Pascal Baltzer, Panagiotis Kapetas, Thomas Helbich, Paola Clauser, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Benedikt M. Schaarschmidt, Andreas Stang, Lale Umutlu, Gerald Antoch, Julian Caspers and Julian Kirchner
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 304-311; DOI: https://doi.org/10.2967/jnumed.122.264138

Radiobiology/Dosimetry

  • Clinical

    • Fetal Dose from PET and CT in Pregnant Patients
      You have access
      Fetal Dose from PET and CT in Pregnant Patients
      Christiane Sarah Burton, Kirk Frey, Frederic Fahey, Mark S. Kaminski, Richard K.J. Brown, Judith M. Pohlen and Barry L. Shulkin
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 312-319; DOI: https://doi.org/10.2967/jnumed.122.263959
  • Translational

    • First-in-Humans Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging
      Open Access
      First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging
      Richard Laforest, Anchal Ghai, Tyler J. Fraum, Reiko Oyama, Jennifer Frye, Helen Kaemmerer, Greg Gaehle, Tom Voller, Cedric Mpoy, Buck E. Rogers, Mark Fiala, Kooresh I. Shoghi, Samuel Achilefu, Michael Rettig, Ravi Vij, John F. DiPersio, Sally Schwarz, Monica Shokeen and Farrokh Dehdashti
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 320-328; DOI: https://doi.org/10.2967/jnumed.122.264349
    • Lesion Quantification Accuracy of Digital <sup>90</sup>Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide Therapy
      You have access
      Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide Therapy
      David Kersting, Walter Jentzen, Daniel Jeromin, Ilektra-Antonia Mavroeidi, Maurizio Conti, Florian Büther, Ken Herrmann, Christoph Rischpler, Rainer Hamacher, Wolfgang P. Fendler, Robert Seifert and Pedro Fragoso Costa
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 329-336; DOI: https://doi.org/10.2967/jnumed.122.264338

Illustrated Post

  • Clinical

    • You have access
      First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma
      Nils Florian Trautwein, Gerald Reischl, Christian Seitz, Helmut Dittmann, Ferdinand Seith, Sophia Scheuermann, Tobias Feuchtinger, Frank Dombrowski, Rupert Handgretinger, Jörg Fuchs, Bernd Pichler, Christian la Fougère and Johannes Schwenck
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 337-338; DOI: https://doi.org/10.2967/jnumed.122.264626

Letters to the Editor

  • You have access
    Dosimetry in Radiopharmaceutical Therapy
    Michael Stabin
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 339; DOI: https://doi.org/10.2967/jnumed.122.265056
  • You have access
    Reply: Dosimetry in Radiopharmaceutical Therapy
    Joe O’Donoghue, Pat Zanzonico, John Humm and Adam Kesner
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 339-340; DOI: https://doi.org/10.2967/jnumed.122.265078

Departments

  • You have access
    Nuclear Medicine: The Essentials
    Abass Alavi
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 341; DOI: https://doi.org/10.2967/jnumed.122.264788
  • You have access
    In Memoriam
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 342;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 64 (2)
Journal of Nuclear Medicine
Vol. 64, Issue 2
February 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant 225Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study
  • 68Ga-DOTATATE Prepared from Cyclotron-Produced 68Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of the Art
  • Hot Topics
  • Issues and Controversies
  • Procedure Standard
  • Theranostics
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
      • INVITED PERSPECTIVE
    • Translational
      • FEATURED TRANSLATIONAL SCIENCE ARTICLE
  • Oncology
    • Clinical
  • Cardiology
    • Clinical
  • Neurology
    • Clinical
      • SPECIAL CONTRIBUTION
  • AI/Advanced Image Analysis
    • Clinical
  • Radiobiology/Dosimetry
    • Clinical
    • Translational
  • Illustrated Post
    • Clinical
  • Letters to the Editor
  • Departments
  • Most Cited
  • Most Read
Loading
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
  • Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
  • Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire